![[höher]](/style/images/multi_up.png)
Eine Ebene höherGruppiert nach:
Dokumententyp
| Veröffentlichungsdatum
Springe zu: Zeitschriftenartikel
Anzahl der Publikationen: 7
Zeitschriftenartikel
Hehlmann, Rüdiger; Lauseker, Michael 
ORCID: https://orcid.org/0000-0002-6662-7127; Voskanyan, Astghik; Fabarius, Alice; Haferlach, Claudia ORCID: https://orcid.org/0000-0002-6333-5049; Hochhaus, Andreas ORCID: https://orcid.org/0000-0003-0626-0834 und Saußele, Susanne ORCID: https://orcid.org/0000-0003-0357-5785
(2022):
Impact of emerging ACA on survival in chronic myeloid leukemia (CML).
In: Leukemia, Bd. 36: S. 2544-2547
[PDF, 1MB]
ORCID: https://orcid.org/0000-0002-6662-7127; Voskanyan, Astghik; Fabarius, Alice; Haferlach, Claudia ORCID: https://orcid.org/0000-0002-6333-5049; Hochhaus, Andreas ORCID: https://orcid.org/0000-0003-0626-0834 und Saußele, Susanne ORCID: https://orcid.org/0000-0003-0357-5785
(2022):
Impact of emerging ACA on survival in chronic myeloid leukemia (CML).
In: Leukemia, Bd. 36: S. 2544-2547
[PDF, 1MB]
Schwaab, Juliana; Naumann, Nicole; Luebke, Johannes; Jawhar, Mohamad; Somervaille, Tim C. P.; Williams, Mark S.; Frewin, Rebecca; Jost, Philipp J.; Lichtenegger, Felix S.; La Rosee, Paul; Storch, Nicola; Haferlach, Torsten; Horny, Hans-Peter; Fabarius, Alice; Haferlach, Claudia; Burchert, Andreas; Hofmann, Wolf-Karsten; Cross, Nicholas C. P.; Hochhaus, Andreas; Reiter, Andreas und Metzgeroth, Georgia
(2020):
Response to tyrosine kinase inhibitors in myeloid neoplasms associated with PCM1-JAK2, BCR-JAK2 and ETV6-ABL1 fusion genes.
In: American Journal of Hematology, Bd. 95, Nr. 7: S. 824-833
Naumann, Nicole; Jawhar, Mohamad; Schwaab, Juliana; Kluger, Sebastian; Luebke, Johannes; Metzgeroth, Georgia; Popp, Henning D.; Khaled, Nada; Horny, Hans-Peter; Sotlar, Karl; Valent, Peter; Haferlach, Claudia; Goehring, Gudrun; Schlegelberger, Brigitte; Meggendorfer, Manja; Hofmann, Wolf-Karsten; Cross, Nicholas C. P.; Reiter, Andreas und Fabarius, Alice
(2018):
Incidence and prognostic impact of cytogenetic aberrations in patients with systemic mastocytosis.
In: Genes Chromosomes & Cancer, Bd. 57, Nr. 5: S. 252-259
Lengfelder, Eva; Goerlich, Dennis; Nowak, Daniel; Spiekermann, Karsten; Haferlach, Claudia; Krug, Utz; Kreuzer, Karl-Anton; Braess, Jan; Schliemann, Christoph; Lindemann, Hans-Walter; Horst, Heinz A.; Schiel, Xaver; Flasshove, Michael; Hecht, Anna; Schnittger, Susanne; Schneider, Stephanie; Wörmann, Bernhard; Hofmann, Wolf-Karsten; Berdel, Wolfgang E.; Bormann, Eike; Sauerland, Cristina; Büchner, Thomas und Hiddemann, Wolfgang
(2018):
Frontline therapy of acute promyelocytic leukemia: Randomized comparison of ATRA and intensified chemotherapy versus ATRA and anthracyclines.
In: European Journal of Haematology, Bd. 100, Nr. 2: S. 154-162
Alpermann, Tamara; Schnittger, Susanne; Eder, Christiane; Dicker, Frank; Meggendorfer, Manja; Kern, Wolfgang; Schmid, Christoph; Aul, Carlo; Staib, Peter; Wendtner, Clemens-Martin; Schmitz, Norbert; Haferlach, Claudia und Haferlach, Torsten
(2016):
Molecular subtypes of NPM1 mutations have different clinical profiles, specific patterns of accompanying molecular mutations and varying outcomes in intermediate risk acute myeloid leukemia.
In: Haematologica, Bd. 101, Nr. 2, E55-E58
Lauseker, Michael; Hanfstein, Benjamin; Haferlach, Claudia; Schnittger, Susanne; Pfirrmann, Markus; Fabarius, Alice; Schlegelberger, Brigitte; Saußele, Susanne; Dietz, Christian T.; Erben, Philipp; Hehlmann, Rüdiger; Hasford, Joerg; Hochhaus, Andreas und Müller, Martin C.
(November 2014):
Equivalence of BCR-ABL transcript levels with complete cytogenetic remission in patients with chronic myeloid leukemia in chronic phase.
In: Journal of cancer research and clinical oncology, Bd. 140, Nr. 11: S. 1965-1969
Hanfstein, Benjamin; Lauseker, Michael; Hehlmann, Rüdiger; Saussele, Susanne; Erben, Philipp; Dietz, Christian; Fabarius, Alice; Proetel, Ulrike; Schnittger, Susanne; Haferlach, Claudia; Krause, Stefan W.; Schubert, Joerg; Einsele, Hermann; Hänel, Mathias; Dengler, Jolanta; Falge, Christiane; Kanz, Lothar; Neubauer, Andreas; Kneba, Michael; Stegelmann, Frank; Pfreundschuh, Michael; Waller, Cornelius F.; Spiekermann, Karsten; Baerlocher, Gabriela M.; Pfirrmann, Markus; Hasford, Jörg; Hofmann, Wolf-Karsten; Hochhaus, Andreas und Müller, Martin C.
(2014):
Distinct characteristics of e13a2 versus e14a2 BCR-ABL1 driven chronic myeloid leukemia under first-line therapy with imatinib.
In: Haematologica, Bd. 99, Nr. 9: S. 1441-1447
[PDF, 784kB]